Influenza vaccination has shown itself to be capable of producing an adequate immunologic response in subjects with diabetes, proving effective in reducing mortality and morbidity in patients with underlying chronic diseases, including diabetes, and reducing hospital admissions among diabetic patients during influenza epidemics (3-8).
For over a decade, Spanish and U.S. health authorities been recommending annual influenza vaccination for subjects who suffer diabetes (2,9,10).
To our knowledge, no nationwide campaigns exclusively targeting people with diabetes were conducted in Spain by either public or private institutions across the study period.
Based on data drawn from the 1993 and 2001 Spanish National Health Surveys (NHS), this study was aimed at 1) ascertaining influenza vaccination coverages among Spanish diabetic adults for years 1993 and 2001, 2) analyzing which factors were associated with the likelihood of persons with diabetes being vaccinated, and 3) analyzing the time trend in influenza vaccination coverages for the period 1993-2001.
RESEARCH DESIGN AND
METHODS -A descriptive crosssectional study was conducted on adult subjects (age Ն16 years) in Spain using individualized secondary data furnished by the 1993 and 2001 NHS. These surveys cover a representative sample of Spain's noninstitutionalized population. The 1993 and 2001 NHS used multistage, stratified cluster sampling, with proportional random selection of primary and secondary sampling units (towns and sections, respectively) and selection of the final units (individuals) by means of random routes and sex-and age-based quotas (11,12).
Subjects were classified as having diabetes if they answered affirmatively to either or both of the following questions: "Has your doctor told you that you are currently suffering from diabetes?" and/or "Have you taken any medication to treat diabetes in the last two weeks?"
To assess influenza vaccination status we considered the response to the question "Did you have a flu shot in the latest campaign?" The independent variables analyzed are shown in Table 1 .
Statistical analysis
We first calculated the prevalence of diabetic subjects and the proportion of these who reported having been vaccinated against influenza (coverages) for each of the two NHSs. Second, influenza vaccination coverages in each of the two surveys were calculated according to the study variables and then compared. Third, multivariate logistic regression models were generated so that we could determine which of the variables covered were independently associated with influenza vaccination in each of the two surveys. 17.5%). In both years, after adjusting for potential confounders (age, sex, and comorbidity), the likelihood of being vaccinated was significantly higher among diabetic than among nondiabetic subjects (OR ϭ 1.68 and 1.65, respectively). Table 1 shows the crude vaccination coverages broken down by sociodemographic and health-related variables. The multivariate analysis showed that in 1993, the three variables that were independently and significantly associated
with a higher likelihood of receiving the vaccine were age, presence of comorbidity, and male sex. Hence, vis-à-vis the reference category (16 - CONCLUSIONS -The most relevant results of this study are that influenza vaccination coverages among Spanish diabetic adults are below desirable levels and that, after controlling for the influence of confounding variables, there has been no significant improvement in coverage between 1993 and 2001.
Arguably, the main limitation of this study is that the use of unvalidated selfreport data on vaccination might entail possible bias. In this respect, however, several studies observe that self-response on influenza vaccination is highly sensitive and evinces a high degree of agreement (13-15).
The coverages described for Spain are appreciably lower than those reported for the U.S. and other European countries (16 -25) .
The usefulness of organizational and educational improvements achieved by health organizations and services for the purpose of enhancing vaccination coverages in high-risk groups in general and individuals with diabetes in particular, has been stressed by different authors (22,26 -32) . The situation among Spanish diabetic adults calls for the implementation of strategies aimed at improving the use of influenza vaccine. 
